Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

The Nanobioengineering Laboratory Leads The Nanometric Scale Research Of A European Project Focused On The Differentiation Of St

23.07.2004


The director of the Nanobioengineering Laboratory of the CREBEC and sub-director of the Parc Científic de Barcelona (PCB, Barcelona Science Park), Josep Samitier, will coordinate the research lines on the application of nanobiotechnologies for the differentiation of stem cells in the European project entitled CellPROM, the most funded project in the first call of the VI Framework Programme. Josep Samitier will preside the CellPROM Scientific Committee on Nanotechnologies and will join its Management Committee, together with the coordinator of basic research, Andreas Manz, and the coordinator of CellPROM, Gunter Führ, from the Fraunhofer Institut Biomedizinische Technik.

In addition, the Nanobioengineering Laboratory also coordinates the broadest line of research in the project, accounting for 34% of the scientific effort, which focuses on the development of artificial surfaces that allow the controlled differentiation of stem cells whilst simultaneously minimizing their rejection once implanted in the patient.

The project is based on the premise that stem cells can be differentiated through interactions that take place at the cell surface. The final objective of CellPROM is to develop technologies with therapeutic applications in the field of the so-called tissue engineering by applying the tools provided by nanotechnology and the know-how on the differentiation of adult stem cells. Specifically, by producing cell cultures and tissues that can be used for auto-transplants, the project will allow Europe to lead the development in the new medical technology required to use stem cells for regenerative therapies.



At present, regenerative therapies are underway that, for example, use bone marrow-derived adult stem cells cultured in the laboratory, which are then implanted. CellPROM will develop surfaces that mimic biological ones, on which stem cells can be cultured through molecular signals that facilitate a more precise differentiation into the cells of interest.

Furthermore, the resulting cell cultures can also be used as alternatives to assays that involve experimental animals. These advances will have practical applications in the fields of new medical technology and in the biotechnology, pharmaceutical and agroalimentary sectors.

The final outcome of CellPROM will be a prototype that cannot be used in humans until it has passed the clinical trial phases, which will be started shortly.
The project includes the participation of 27 institutions from 12 European countries, which include prestigious institutes and centres such as the PasteurInstitute in France, the Royal Institute of Technology of Sweden, the University of Vienna and the Institute of Pharmaceutical Technology of Austria, the Swiss Federal Institute of Technology, Lausanne, the Fraunhofer Society of Germany and the University of Barcelona, through the Nanobioengineering Laboratory.

The CellPROM project has a total budget of more than 26 million Euros, 17.6 million of which have been granted by the European Commission. The project was officially presented in Saarbrücken, Germany, on 25 and 26 March 2004.

Rosina Malagrida | alfa
Further information:
http://www.pcb.ub.es

More articles from Life Sciences:

nachricht New Technique Maps Elusive Chemical Markers on Proteins
03.07.2015 | Salk Institute for Biological Studies

nachricht New approach to targeted cancer therapy
03.07.2015 | CECAD - Cluster of Excellence at the University of Cologne

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Viaducts with wind turbines, the new renewable energy source

Wind turbines could be installed under some of the biggest bridges on the road network to produce electricity. So it is confirmed by calculations carried out by a European researchers team, that have taken a viaduct in the Canary Islands as a reference. This concept could be applied in heavily built-up territories or natural areas with new constructions limitations.

The Juncal Viaduct, in Gran Canaria, has served as a reference for Spanish and British researchers to verify that the wind blowing between the pillars on this...

Im Focus: X-rays and electrons join forces to map catalytic reactions in real-time

New technique combines electron microscopy and synchrotron X-rays to track chemical reactions under real operating conditions

A new technique pioneered at the U.S. Department of Energy's Brookhaven National Laboratory reveals atomic-scale changes during catalytic reactions in real...

Im Focus: Iron: A biological element?

Think of an object made of iron: An I-beam, a car frame, a nail. Now imagine that half of the iron in that object owes its existence to bacteria living two and a half billion years ago.

Think of an object made of iron: An I-beam, a car frame, a nail. Now imagine that half of the iron in that object owes its existence to bacteria living two and...

Im Focus: Thousands of Droplets for Diagnostics

Researchers develop new method enabling DNA molecules to be counted in just 30 minutes

A team of scientists including PhD student Friedrich Schuler from the Laboratory of MEMS Applications at the Department of Microsystems Engineering (IMTEK) of...

Im Focus: Bionic eye clinical trial results show long-term safety, efficacy vision-restoring implant

Patients using Argus II experienced significant improvement in visual function and quality of life

The three-year clinical trial results of the retinal implant popularly known as the "bionic eye," have proven the long-term efficacy, safety and reliability of...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

World Conference on Regenerative Medicine in Leipzig: Last chance to submit abstracts until 2 July

25.06.2015 | Event News

World Conference on Regenerative Medicine: Abstract Submission has been extended to 24 June

16.06.2015 | Event News

MUSE hosting Europe’s largest science communication conference

11.06.2015 | Event News

 
Latest News

Siemens receives order for offshore wind power plant in Great Britain

03.07.2015 | Press release

'Déjà vu all over again:' Research shows 'mulch fungus' causes turfgrass disease

03.07.2015 | Agricultural and Forestry Science

Discovery points to a new path toward a universal flu vaccine

03.07.2015 | Health and Medicine

VideoLinks
B2B-VideoLinks
More VideoLinks >>>